Brief: Evelo Biosciences reports Q2 results

Evelo Biosciences

11/08/2022 11:02

Aug 11 (Reuters) - Evelo Biosciences Inc  EVLO.O :
    * AS OF JUNE 30, 2022, CASH AND CASH EQUIVALENTS WERE $92.0
MILLION
    * LOSS PER BASIC AND DILUTED SHARES WERE $0.40 FOR THREE
MONTHS
ENDED JUNE 30, 2022
    * Q2 EARNINGS PER SHARE VIEW $-0.43 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXc6QBRZ 
Further company coverage:  EVLO.O